NCT06972940View on ClinicalTrials.gov

A Prospective, Multicenter, Randomized, No-treatment Controlled, Assessor-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Gel for Injection to Improve Temple Hollowing in Chinese Adults

NARecruitingINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

October 12, 2024

Study Completion Date

December 31, 2025

Conditions
Temple Hollowing
Interventions
DEVICE

Polycaprolactone (PCL) Based Facial Injectable

Polycaprolactone (PCL) Based Facial Injectable

Trial Locations (1)

Unknown

RECRUITING

Beijing Peking University First Hospital, Beijing

Sponsors

Lead Sponsor

AQTIS Medical B.V.
All Listed Sponsors
lead

AQTIS Medical B.V.

OTHER

NCT06972940 - A Prospective, Multicenter, Randomized, No-treatment Controlled, Assessor-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Gel for Injection to Improve Temple Hollowing in Chinese Adults | Biotech Hunter | Biotech Hunter